AACR Late Breaking Abstract selected:
Abstract Number: LB-084
Presentation Title: Go-TCR™: Inducible MyD88/CD40 (iMC) enhances proliferation and survival of tumor-specific TCR-modified T cells, increasing anti-tumor efficacy
Presentation Time: Monday, Apr 18, 2016, 8:00 AM -12:00 PM
Location: Section 10
Author Block: David M. Spencer1, Tsvetelina P. Hoang1, Aaron Foster1, Tania Rodriguez1, David Torres1, An Lu1, Jeannette Crisostomo1, Lorenz Jahn2, Mirjam H.M. Heemskerk2. 1Bellicum Pharmaceuticals, Houston, TX; 2Leiden Univ Medical Center, Leiden, Netherlands
